Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival

Basal-like breast cancer is an aggressive tumor subtype with poor prognosis. The discovery of underlying mechanisms mediating tumor cell survival, and the development of novel agents to target these pathways, is a priority for patients with basal-like breast cancer. From a functional screen to ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiong, Kai Hung, Tan, Boon Shing, Choo, Heng Lungh, Chung, Felicia Fei-Lei, Hii, Ling-Wei, Tan, Si Hoey, Khor, Nelson Tze Woei, Wong, Shew Fung, See, Sze-Jia, Tan, Yuen-Fen, Rosli, Rozita, Cheong, Soon-Keng, Leong, Chee-Onn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295378/
https://www.ncbi.nlm.nih.gov/pubmed/27192118
http://dx.doi.org/10.18632/oncotarget.9328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295378/
https://www.ncbi.nlm.nih.gov/pubmed/27192118
http://dx.doi.org/10.18632/oncotarget.9328

Ejemplares similares